Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Nov 9, 2010 · 10-Q · 40 days after period end · 0000012208-10-000123
| Metric | Q3 2010 | Q3 2009 |
|---|---|---|
| Revenue | $471.50M | $461.06M |
| Net Income | $44.80M | $38.52M |
| EPS Diluted | $1.59 | $1.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Sep 30, 2010 · filed Nov 9, 2010 · 40 d after period end
